Permethrin Completed Phase 3 Trials for Scabies Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03973775A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimiteā„¢ in Subjects With Scabies
NCT03178942Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies
NCT02978508Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
NCT02572986A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to ElimiteĀ® in the Treatment of Scabies